Search
Close this search box.

Takeda vet Tanigaki named CEO of Aculys

ARTICLE | Management Tracks

Plus: Lonza names Wolfgang Wienand CEO, and updates from Verily, GSK, NewAmsterdam, Voyager, Adaptive, Ratio, Adlai Nortye and I-Mab

By Gunjan Ohri, Data Content Analyst, and Jeff Cranmer, Executive Editor

April 3, 2024 1:02 AM UTC

Hidemasa Tanigaki, a longtime veteran of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK), joined Tokyo-based Aculys Pharma Inc. as CEO. Tanigaki held multiple leadership positions over the past decade at Takeda, most recently head of the GI disease business unit. He also served as president of Nihon Pharmaceutical Co. Ltd. Takeshi Takahashi will step down as interim CEO and remain a director.

Lonza Group Ltd. (SIX:LONN) named Wolfgang Wienand CEO, effective in summer. Wienand, who will succeed Albert Baehny, is CEO of fellow Swiss CDMO Siegfried Holding AG. Chairman and CEO Baehny, who has been in the CEO role on an interim basis since Pierre-Alain Ruffieux’s departure last fall, is retiring. …